Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-18 5:24 pm Purchase | 2023-05-17 | 13D | Alimera Sciences, Inc. ALIM | Caligan Partners LP | 915,057,915,057 9.990% | 915,057,190,341 (+126264245.63%) | Filing History |
| 2023-04-03 2:24 pm Sale | 2023-03-24 | 13G | Alimera Sciences, Inc. ALIM | Palo Alto Investors LP | 0 0.000% | -802,423 (Position Closed) | Filing History |
| 2023-03-31 11:00 am Purchase | 2023-03-24 | 13D | Alimera Sciences, Inc. ALIM | Velan Capital Investment Management LP | 749,750 9.990% | 749,750 (New Position) | Filing History |
| 2023-03-28 5:00 pm Purchase | 2023-03-24 | 13D | Alimera Sciences, Inc. ALIM | Caligan Partners LP | 724,716 9.990% | 313,189 (+76.10%) | Filing History |
| 2023-02-14 4:12 pm Unchanged | 2022-12-31 | 13G | Alimera Sciences, Inc. ALIM | Palo Alto Investors LP | 802,423 11.450% | 0 (Unchanged) | Filing History |
| 2023-02-08 2:41 pm Purchase | 2022-12-30 | 13G | Alimera Sciences, Inc. ALIM | MORGAN STANLEY MS | 666,246 9.500% | 102,922 (+18.27%) | Filing History |
| 2022-10-27 4:23 pm Sale | 2022-02-28 | 13G | Alimera Sciences, Inc. ALIM | MORGAN STANLEY MS | 563,324 8.100% | -356,222 (-38.74%) | Filing History |
| 2022-05-25 5:18 pm Purchase | 2022-05-19 | 13D | Alimera Sciences, Inc. ALIM | Caligan Partners LP | 411,527 5.900% | 411,527 (New Position) | Filing History |
| 2022-03-10 4:21 pm Purchase | 2022-02-28 | 13G | Alimera Sciences, Inc. ALIM | MORGAN STANLEY MS | 919,546 13.300% | 490,000 (+114.07%) | Filing History |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | Alimera Sciences, Inc. ALIM | Palo Alto Investors LP | 802,423 11.570% | 802,423 (New Position) | Filing History |
| 2022-02-10 2:33 pm Purchase | 2021-12-31 | 13G | Alimera Sciences, Inc. ALIM | MORGAN STANLEY MS | 429,546 6.200% | 8,834 (+2.10%) | Filing History |
| 2022-02-03 4:05 pm Sale | 2022-02-02 | 13G | Alimera Sciences, Inc. ALIM | Orin Hirschman | 0 0.000% | -501,025 (Position Closed) | Filing History |
| 2021-04-30 1:16 pm Purchase | 2021-04-16 | 13G | Alimera Sciences, Inc. ALIM | Ocumension Therapeutics | 1,144,945 16.620% | 1,144,945 (New Position) | Filing History |
| 2021-02-16 4:20 pm Purchase | 2020-12-31 | 13G | Alimera Sciences, Inc. ALIM | Palo Alto Investors LP | 802,423 15.640% | 802,423 (New Position) | Filing History |
| 2021-02-12 12:40 pm Sale | 2020-12-31 | 13G | Alimera Sciences, Inc. ALIM | James E. Flynn | 0 0.000% | -676,667 (Position Closed) | Filing History |
| 2021-02-12 08:11 am Sale | 2020-12-31 | 13G | Alimera Sciences, Inc. ALIM | Avoro Capital Advisors LLC | 0 0.000% | -415,999 (Position Closed) | Filing History |
| 2021-02-10 4:18 pm Purchase | 2020-12-31 | 13G | Alimera Sciences, Inc. ALIM | Orin Hirschman | 501,025 11.000% | 28,000 (+5.92%) | Filing History |
| 2021-02-10 11:28 am Sale | 2020-12-31 | 13G | Alimera Sciences, Inc. ALIM | MORGAN STANLEY MS | 420,712 8.200% | -26 (-0.01%) | Filing History |
| 2020-11-09 4:20 pm Purchase | 2020-10-30 | 13G | Alimera Sciences, Inc. ALIM | MORGAN STANLEY MS | 420,738 8.200% | 420,738 (New Position) | Filing History |
| 2020-09-29 4:44 pm Purchase | 2020-09-29 | 13D | Alimera Sciences, Inc. ALIM | Domain Partners VI L.P. | 239,394 4.800% | 239,394 (New Position) | Filing History |